NSPR
InspireMD, Inc.
Latest Form 4:Purchase$18KbyStuka Paul (Director) · filed May 29, 2026
InspireMD, Inc. (NSPR) has 27 SEC Form 4 filings (54 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: May 29, 2026.
Inside the rolling window, 5 insiders at InspireMD, Inc. reported 15 open-market purchases totaling $430K and 23 open-market sales totaling $289K. The most active filer is Chief Commercial Officer Gleason Shane Thomas with 23 filings. Insiders have net bought $119K over the trailing 6 months. The most recent open-market filing is a purchase of 20,000 shares by Director Stuka Paul, dated May 27, 2026, worth $18K.
- Industry:Medical - Devices
- CEO:Marvin L. Slosman
- Employees:127
- HQ:Miami, IL
- IPO:2011-04-12
Insider Buying
$430K
reported purchases (SEC code P)
Insider Selling
$289K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$43.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 20,000 | $18K | May 29 | SEC ↗ | |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 3,858 | $10K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 2,476 | $6K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 3,660 | $9K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 2,454 | $6K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 9,923 | $25K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 7,073 | $18K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 5,132 | $13K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 10,000 | $37K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 2,482 | $6K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 1,572 | $4K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 3,760 | $9K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 7,186 | $18K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 4,941 | $8K | May 21 | SEC ↗ |
Gleason Shane ThomasFirst in 4 months | Chief Commercial Officer | Sale | 22,778 | $23K | May 21 | SEC ↗ |
| Director | Purchase | 10,000 | $12K | May 15 | SEC ↗ | |
| Director | Purchase | 5,000 | $6K | May 15 | SEC ↗ | |
| Director | Purchase | 65,626 | $76K | May 13 | SEC ↗ | |
| Director | Purchase | 10,000 | $12K | May 13 | SEC ↗ | |
Slosman MarvinFirst filing | CEO and President | Purchase | 21,000 | $25K | May 13 | SEC ↗ |
Ward Scott R.First filing | Director | Purchase | 15,995 | $18K | May 8 | SEC ↗ |
Ward Scott R.First filing | Director | Purchase | 73,255 | $84K | May 8 | SEC ↗ |
| Director | Purchase | 1,517 | $2K | May 8 | SEC ↗ | |
| Director | Purchase | 6,378 | $7K | May 8 | SEC ↗ | |
ROUBIN GARY SFirst filing | Director | Purchase | 90,000 | $106K | May 8 | SEC ↗ |
| Director | Purchase | 7,783 | $14K | Feb 23 | SEC ↗ | |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 2,909 | $5K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 2,250 | $4K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 2,955 | $5K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 17,593 | $29K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 8,411 | $13K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 4,781 | $8K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 12,395 | $20K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 5,000 | $8K | Feb 2 | SEC ↗ |
Gleason Shane ThomasFirst filing | Chief Commercial Officer | Sale | 2,900 | $5K | Feb 2 | SEC ↗ |
| Director | Purchase | 5,073 | $9K | Dec 8 | SEC ↗ | |
| Director | Purchase | 10,130 | $19K | Dec 5 | SEC ↗ | |
Stuka PaulFirst filing | Director | Purchase | 13,431 | $22K | Nov 13 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does NSPR have?
InspireMD, Inc. (NSPR) has 27 SEC Form 4 filings (54 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: May 29, 2026.
When was the most recent SEC Form 4 filing for NSPR?
The most recent Form 4 filing for NSPR on Tracefour is dated May 29, 2026.
Who is the most active insider at NSPR?
The most active SEC Form 4 filer at NSPR in the rolling window is Chief Commercial Officer Gleason Shane Thomas, with 23 filings.
What is the net insider flow at NSPR over the last 6 months?
Over the trailing 180 days, insiders at NSPR have net bought $119K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NSPR in the current window?
Inside the rolling window, insiders at NSPR bought $430K and sold $289K based on SEC Form 4 filings.
Can I get alerts for NSPR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at InspireMD, Inc. (NSPR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
InspireMD, Inc. is in the Healthcare sector.